BellBrook, Reaction Biology Partner on Epigenetic-based Assays for Drug Development | GenomeWeb

NEW YORK (GenomeWeb News) – BellBrook Labs and Reaction Biology today announced a deal to develop a methyltransferase assay solution for inhibitor screening and profiling.

The two companies will develop kits that combine required methyltransferase enzyme reaction components from Reaction Biology with BellBrook's Transcreener detection reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.